15 reports

TABLE ##: GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, FORECAST REVENUE BY COMPANY, 2015-2022 Shionogi ## ## ## ## ## ## ## ## -##. ## -##. ## -##. ## Ipsen - ## ## ## ## ## ## ## - - ##. ## GW - - ## ## ## ## ## ## ##. ## ##. ## ##. ## Almirall - ## ##

  • Gastrointestinal Drug
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

Chapter III ##BPharmaceuticals Industry Capacity PHARMACEUTICALS INDUSTRY ASSESSMENTS At present, life science research has entered the post-genome era and many new products ranging from drug targeting, gene therapy and stem cell research has made some outcomes.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

Drivers and their Impact Impact on key customer category disease Increase in patient population Regulatory and distribution channel Non-complex etiology Growing geriatric population framework Low Low ## ## ## ## ## High High ## ## ## ## ## ## ## ## ## ## Low High ## ## ## ## ##

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.

Patients were randomly assigned to one of two arms - one arm received Insegia alone, the other arm received placebo.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Ironwood Pharmaceuticals, Inc.
  • Gastrointestinal Disorders, Global, First-in-Class Programs with and without Prior Involvement in Licensing or
  • Gastrointestinal Disorders, Global, List of All Pipeline Products, 2019 (part 2)

PLOS One.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • World
  • Deals & Alliance

H+/ K(+) ATPase exports hydrogen ions in ##:## exchange for potassium ions, which results in the secretion of gastric acid.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Litigation And Patent
  • AstraZeneca PLC

The company revenue from India grew by ##% to ##. ## billion.

  • Gastrointestinal Drug
  • United States
  • World
  • Forecast
  • Boehringer Ingelheim GmbH

The molecules developed by Companies in Pre-Registration, Phase II, Phase I, IND/ CTA Filed and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • United States
  • Litigation And Patent
  • AstraZeneca PLC

ASP-## is a selective COX ##(cyclooxygenases-##) inhibitor.

  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • Litigation And Patent
  • AstraZeneca PLC
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • Product Initiative

(Boryung) is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE).

  • Gastrointestinal Drug
  • United States
  • Litigation And Patent
  • Product Initiative
  • AstraZeneca PLC
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC

Three dose levels of F-## (##, ##, and ## g/ kg) vs. pegfilgrastim were tested in patients receiving the TC regimen, with a randomization ratio of ##:##:##:##.

  • Chemotherapy
  • Gastrointestinal Drug
  • Neurological Disorder
  • Pharmaceutical
  • Product Initiative

Product Description GENE THERAPY TO ACTIVATE MVCHR## FOR RETINITS PIGMENTOSA Gene therapy is under development for the treatment of retinitis pigmentosa.

  • Cell Therapy
  • Gastrointestinal Drug
  • Pharmaceutical
  • Research And Development
  • Astellas Pharma Inc.
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative